Nonthrombotic Pulmonary Embolism Associated With Non-Hodgkin Lymphoma

Gil-Garcia, Cesar-Alejandro; Cueto-Robledo, Guillermo; González-Hermosillo, Leslie-Marisol; Alfaro-Cruz, Ana; Roldan-Valadez, Ernesto

doi:10.1016/j.cpcardiol.2023.102001

Current Problems in Cardiology

2023

DOI: 10.1016/j.cpcardiol.2023.102001

|View full text |Cite

Nonthrombotic Pulmonary Embolism Associated With Non-Hodgkin Lymphoma

Cesar-Alejandro Gil-Garcia

Guillermo Cueto-Robledo

Leslie-Marisol González-Hermosillo

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Impacts of COVID-19 on hemostasis: coagulation abnormalities and management perspectives

Obeagu,

Tukur,

Akaba

2024

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has transcended its initial characterization as a respiratory illness, revealing substantial implications for hemostasis and coagulation pathways. COVID-19-associated coagulopathies have emerged as critical determinants of disease severity and prognosis, presenting a multifaceted challenge in clinical management. This paper aims to elucidate the intricate interplay between COVID-19 and hemostasis, delving into the underlying mechanisms of coagulation abnormalities, exploring the spectrum of thrombotic complications, and discussing evolving management strategies. Therapeutic interventions and anticoagulation strategies tailored for managing COVID-19-related coagulopathies form a significant focus, encompassing prophylactic and therapeutic approaches, heparin-based therapies, and individualized treatment paradigms. This paper underscores the imperative for ongoing research endeavors to refine diagnostic modalities, identify novel therapeutic targets, and ascertain long-term sequelae of COVID-19-induced coagulation abnormalities. Ultimately, a comprehensive understanding of the intricate relationship between COVID-19 and hemostasis is pivotal in devising effective management strategies to mitigate thrombotic risks, improve clinical outcomes, and pave the way for tailored interventions in affected individuals.

show abstract

Impacts of COVID-19 on hemostasis: coagulation abnormalities and management perspectives

Obeagu,

Tukur,

Akaba

2024

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Nonthrombotic Pulmonary Embolism Associated With Non-Hodgkin Lymphoma

Cited by 1 publication

References 50 publications

Impacts of COVID-19 on hemostasis: coagulation abnormalities and management perspectives

Impacts of COVID-19 on hemostasis: coagulation abnormalities and management perspectives

Contact Info

Product

Resources

About